Monte Rosa Therapeutics, Inc. (GLUE)

NASDAQ: GLUE · Real-Time Price · USD

5.10

-0.16 (-3.04%)

At close: Mar 28, 2025, 4:00 PM

5.12

+0.02 (0.41%)

After-hours: Mar 28, 2025, 7:51 PM EDT

Monte Rosa Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Revenue	75.62	-	-	-	-	Upgrade
Cost of Revenue	112.86	103.37	-	-	-	Upgrade
Gross Profit	-37.24	-103.37	-	-	-	Upgrade
Selling, General & Admin	43.87	39.94	35.12	15.73	4.01	Upgrade
Research & Development	-	-	77.26	57.16	24.01	Upgrade
Operating Expenses	43.87	39.94	112.38	72.88	28.01	Upgrade
Operating Income	-81.11	-143.31	-112.38	-72.88	-28.01	Upgrade
Interest & Investment Income	10.57	9.33	3.76	0.05	0.01	Upgrade
Currency Exchange Gain (Loss)	0.42	-0.93	0.01	-0.16	-0.2	Upgrade
Other Non Operating Income (Expenses)	-	-	-	-0.96	-7.68	Upgrade
EBT Excluding Unusual Items	-70.13	-134.91	-108.61	-73.96	-35.88	Upgrade
Gain (Loss) on Sale of Investments	-	-0.13	-	-	-	Upgrade
Gain (Loss) on Sale of Assets	-	0.02	0.11	-	-	Upgrade
Pretax Income	-70.13	-135.01	-108.5	-73.96	-35.88	Upgrade
Income Tax Expense	2.57	0.34	-	-	-	Upgrade
Net Income	-72.7	-135.35	-108.5	-73.96	-35.88	Upgrade
Net Income to Common	-72.7	-135.35	-108.5	-73.96	-35.88	Upgrade
Shares Outstanding (Basic)	74	51	47	25	2	Upgrade
Shares Outstanding (Diluted)	74	51	47	25	2	Upgrade
Shares Change (YoY)	43.80%	8.83%	88.91%	1548.09%	7.11%	Upgrade
EPS (Basic)	-0.98	-2.63	-2.30	-2.96	-23.65	Upgrade
EPS (Diluted)	-0.98	-2.63	-2.30	-2.96	-23.65	Upgrade
Free Cash Flow	38.01	-62.84	-105.38	-69.1	-26.44	Upgrade
Free Cash Flow Per Share	0.51	-1.22	-2.23	-2.76	-17.43	Upgrade
Gross Margin	-49.25%	-	-	-	-	Upgrade
Operating Margin	-107.26%	-	-	-	-	Upgrade
Profit Margin	-96.14%	-	-	-	-	Upgrade
Free Cash Flow Margin	50.26%	-	-	-	-	Upgrade
EBITDA	-72.99	-137.09	-108.64	-70.75	-27.47	Upgrade
EBITDA Margin	-96.52%	-	-	-	-	Upgrade
D&A For EBITDA	8.12	6.22	3.75	2.13	0.54	Upgrade
EBIT	-81.11	-143.31	-112.38	-72.88	-28.01	Upgrade
EBIT Margin	-107.26%	-	-	-	-	Upgrade

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q